Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
Immunofluorescence analysis of HDAC2 was done on 70% confluent log phase A431 cells. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 10 minutes, and blocked with 1% BSA for 1 hour at room temperature. The cells were labeled with HDAC2 Rabbit Polyclonal Antibody (515100) at 2ug/ml in 0.1% BSA and incubated for 3 hours at room temperature and then labeled with Goat anti-Rabbit IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor® 488 conjugate (Product # A27034) at a dilution of 1:2000 for 45 minutes at room temperature (Panel a: green). Nuclei (Panel b: blue) were stained with SlowFade® Gold Antifade Mountant with DAPI (S36938). F-actin (Panel c: red) was stained with Alexa Fluor® 555 Rhodamine Phalloidin (Product # R415, 1:300). Panel d is a merged image showing nuclear localization. Panel e is a no primary antibody control. The images were captured at 60X magnification.
|Tested species reactivity||Human, Mouse|
|Published species reactivity||Mouse, Human, Not Applicable|
|Host / Isotype||Rabbit / IgG|
|Immunogen||A synthetic 11 amino acid peptide derived from the C-terminus of the mouse HDAC2 protein.|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7.4|
|Contains||0.1% sodium azide|
|Tested Applications||Dilution *|
|ChIP assay (ChIP)||Assay Dependent|
|ELISA (ELISA)||0.1-1.0 ug/ml|
|Flow Cytometry (Flow)||3-5 µg/10^6 cells|
|Immunocytochemistry (ICC)||2-3 µg/mL|
|Immunofluorescence (IF)||2-3 µg/mL|
|Immunohistochemistry (Paraffin) (IHC (P))||1:20|
|Immunoprecipitation (IP)||5 ug|
|Western Blot (WB)||1-3 µg/mL|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
Histone deacetylase 2 (HDAC2), or transcriptional regulator homolog RPD3 L1, is highly homologous to the yeast transcription factor RPD3 (reduced potassium dependency 3) gene. As in yeast, human HDA2 is likely to be involved in regulating chromatin structure during transcription. It has been implicated to associate with YY1, a mammalian zinc-finger transcription factor, which negatively regulates transcription by tethering RPD3 to DNA as a cofactor. This process is highly concerved from yeast to human.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Ctbp2 Modulates NuRD-Mediated Deacetylation of H3K27 and Facilitates PRC2-Mediated H3K27me3 in Active Embryonic Stem Cell Genes During Exit from Pluripotency.
51-5100 was used in ChIP assay to investigate epigenetic changes in embryonic stem cell that control lineage commitment.
|Kim TW,Kang BH,Jang H,Kwak S,Shin J,Kim H,Lee SE,Lee SM,Lee JH,Kim JH,Kim SY,Cho EJ,Kim JH,Park KS,Che JH,Han DW,Kang MJ,Yi EC,Youn HD||Stem cells (Dayton, Ohio) (33:2442)||2015|
Spatial re-organization of myogenic regulatory sequences temporally controls gene expression.
51-5100 was used in ChIP assay to show that the spatial organization of late genes contributes to temporal regulation of myogenic transcription during myogenesis
|Harada A,Mallappa C,Okada S,Butler JT,Baker SP,Lawrence JB,Ohkawa Y,Imbalzano AN||Nucleic acids research (43:2008)||2015|
Histone modifiers, YY1 and p300, regulate the expression of cartilage-specific gene, chondromodulin-I, in mesenchymal stem cells.
51-5100 was used in ChIP assay to explore the molecular mechanisms that regulate decreased ChM-I expression in mesenchymal stem cells
|Aoyama T,Okamoto T,Fukiage K,Otsuka S,Furu M,Ito K,Jin Y,Ueda M,Nagayama S,Nakayama T,Nakamura T,Toguchida J||The Journal of biological chemistry (285:29842)||2010|
|Not Applicable||Not Cited||
Skeletal muscle specification by myogenin and Mef2D via the SWI/SNF ATPase Brg1.
51-5100 was used in ChIP assay to elucidate how myogenin specifies the muscle phenotype
|Ohkawa Y,Marfella CG,Imbalzano AN||The EMBO journal (25:490)||2006|
||Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.||Yokota T,Matsuzaki Y,Miyazawa K,Zindy F,Roussel MF,Sakai T||Oncogene (23:5340)||2004|
|Not Applicable||Not Cited||
Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction.
51-5100 was used in western blot to assess repression of matrix metalloproteinase-2 and -9 expression and preservation of LV function postmyocardial infaction by inhibition of class 1 histone deacetylase activity
|Mani SK,Kern CB,Kimbrough D,Addy B,Kasiganesan H,Rivers WT,Patel RK,Chou JC,Spinale FG,Mukherjee R,Menick DR||American journal of physiology. Heart and circulatory physiology (308:H1391)||2015|
Deacetylase inhibitors repress STAT5-mediated transcription by interfering with bromodomain and extra-terminal (BET) protein function.
51-5100 was used in ChIP assay and western blot to test if deacetylase inhibitors target STAT5 or histone acetylation
|Pinz S,Unser S,Buob D,Fischer P,Jobst B,Rascle A||Nucleic acids research (43:3524)||2015|
Redox-sensitive gene-regulatory events controlling aberrant matrix metalloproteinase-1 expression.
51-5100 was used in western blot to demonstrate that histone deacetylase-2 protein levels and its occupancy of the MMP-1 promoter are decreased in response to enforced manganese superoxide dismutase expression
|Bartling TR,Subbaram S,Clark RR,Chandrasekaran A,Kar S,Melendez JA||Free radical biology and medicine (74:99)||2014|
pVHL-mediated transcriptional repression of c-Myc by recruitment of histone deacetylases.
51-5100 was used in western blot to identify a novel mechanism for pVHL-mediated negative regulation of c-Myc transcription.
|Hwang IY,Roe JS,Seol JH,Kim HR,Cho EJ,Youn HD||Molecules and cells (33:195)||2012|
|Human||Not Cited||Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.||Yokota T,Matsuzaki Y,Miyazawa K,Zindy F,Roussel MF,Sakai T||Oncogene (23:5340)||2004|
|Human||Not Cited||Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription.||Zhang Y,Hamburger AW||The Journal of biological chemistry (279:26126)||2004|
|Human||Not Cited||Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases.||Zhang Y,Woodford N,Xia X,Hamburger AW||Nucleic acids research (31:2168)||2003|
Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells.
51-5100 was used in western blot to describe the systematic analyses of hTERT promoter to understand the transcriptional repression mechanism of the hTERT gene in normal human somatic cells.
|Won J,Yim J,Kim TK||The Journal of biological chemistry (277:38230)||2002|
Contrasting roles for MyoD in organizing myogenic promoter structures during embryonic skeletal muscle development.
51-5100 was used in ChIP assay, immunocytochemistry, immunoprecipitation, and western blot to study the temporal regulation of MyoD in skeletal muscle differentiation
|Cho OH,Mallappa C,Hernández-Hernández JM,Rivera-Pérez JA,Imbalzano AN||Developmental dynamics : an official publication of the American Association of Anatomists (244:43)||2015|
|Not Applicable||Not Cited||
Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
51-5100 was used in immunoprecipitation and western blot to assess the antitumor effects of novel hybrid synthetic histone deacetylase inhibitors on human cancer cells
|Park JH,Jung Y,Kim TY,Kim SG,Jong HS,Lee JW,Kim DK,Lee JS,Kim NK,Kim TY,Bang YJ||Clinical cancer research : an official journal of the American Association for Cancer Research (10:5271)||2004|
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis.
51-5100 was used in immunohistochemistry - paraffin section to study the contribution of HDAC2 to the development of solid tumors
|Zhu P,Martin E,Mengwasser J,Schlag P,Janssen KP,Göttlicher M||Cancer cell (5:455)||2004|
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2.
51-5100 was used in immunohistochemistry - paraffin section to demonstrate that poly-ubiquitination and proteasomal degradation are an isoenzyme-selective mechanism for the downregulation of HDAC2.
|Krämer OH,Zhu P,Ostendorff HP,Golebiewski M,Tiefenbach J,Peters MA,Brill B,Groner B,Bach I,Heinzel T,Göttlicher M||The EMBO journal (22:3411)||2003|
HD2; HDAC2; Histone deacetylase 2; RPD3; transcriptional regulator homolog RPD3; YAF1; YY1 transcription factor-binding protein; YY1-associated factor 1
D10Wsu179e; HD2; HDAC2; mRPD3; RPD3; YAF1; Yy1bp